Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma

Conditions:   Nasopharyngeal Carcinoma;   Radiotherapy;   Chemotherapy Interventions:   Radiation: reduced dosage IMRT;   Radiation: conventional dosage IMRT Sponsors:   Sun Yat-sen University;   National Cancer Centre, Singapore;   Affiliated Cancer Hospital& Institute of Guangzhou Medical University;   Zhongshan People's Hospital, Guangdong, China;   Yuebei People's Hospital;   Wuzhou Red Cross Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials